Literature DB >> 28469969

Vessel morphometric parameters-correlation with histologic grade and VEGF expression in oligodendroglioma.

Leah B Strickland-Marmol1, Steven Brem2,3, Amyn M Rojiani3,4, Mumtaz V Rojiani4.   

Abstract

The contributions of histologic features including microvascular proliferation to the determination of malignancy in oligodendrogliomas remain uncertain. We have retrospectively performed morphometric assessments in 20 tumors histologically classified as well-differentiated (WHO Grade II, n=8) or anaplastic (WHO Grade III, n=12) oligodendrogliomas (WDO or AO). Quantitative studies utilized image analysis of double immunolabeled vasculature with anti CD34 with VIP chromogen (purple) and proliferating nuclei with anti MIB-1, using DAB (brown). Mean values are reported from five fields for each of twenty cases. The total number of MIB-1 positive tumor nuclei was 10 fold higher in AO vs WDO. The area occupied by vessels was also markedly increased in AO vs WDO, as was the microvessel density. Proliferating endothelial cells i.e. those with MIB-1 positive nuclei in CD34 positive cells were significantly increased (4.6 vs 0.26 positive nuclei per unit tumor area, P≤0.001) in AO. While in most areas these changes were evident as typical microvascular proliferation, other areas showed thin walled vessels with increased MIB-1 positivity. VEGF was only assessed morphologically and showed positive staining of vasculature only, in WDO, while AO also showed immunoreactivity of vessels and multiple areas of tumor cells. These findings support a contributory role for vascular proliferation in assessing histologic grade. These findings also suggest that VEGF expression which is confined to blood vessels in lower grade tumors but eventually is expressed by tumor cells in higher grade oligodendrogliomas may be an important factor as the tumor progresses.

Entities:  

Keywords:  Oligodendroglioma; VEGF; grade; vascular proliferation

Year:  2017        PMID: 28469969      PMCID: PMC5411804     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  20 in total

1.  Oligodendroglioma. A comparison of two grading systems.

Authors:  J M Kros; D Troost; C G van Eden; A J van der Werf; H B Uylings
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

2.  The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients.

Authors:  Sarah F Smith; Judy M Simpson; Janice A Brewer; Lali H S Sekhon; Michael T Biggs; Raymond J Cook; Nicholas S Little
Journal:  J Neurooncol       Date:  2006-06-23       Impact factor: 4.130

3.  Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading.

Authors:  C Giannini; B W Scheithauer; A L Weaver; P C Burger; J M Kros; S Mork; M B Graeber; S Bauserman; J C Buckner; J Burton; R Riepe; H D Tazelaar; A G Nascimento; T Crotty; G L Keeney; P Pernicone; H Altermatt
Journal:  J Neuropathol Exp Neurol       Date:  2001-03       Impact factor: 3.685

4.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

5.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

Authors:  C Daumas-Duport; P Varlet; M L Tucker; F Beuvon; P Cervera; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

6.  Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.

Authors:  C Christov; H Adle-Biassette; C Le Guerinel; S Natchev; R K Gherardi
Journal:  Neuropathol Appl Neurobiol       Date:  1998-02       Impact factor: 8.090

7.  Prognostic factors in oligodendroglioma.

Authors:  D Schiffer; A Dutto; P Cavalla; I Bosone; A Chiò; R Villani; C Bellotti
Journal:  Can J Neurol Sci       Date:  1997-11       Impact factor: 2.104

8.  Expression of vascular endothelial growth factor in human brain tumors.

Authors:  R Nishikawa; S Y Cheng; R Nagashima; H J Huang; W K Cavenee; M Matsutani
Journal:  Acta Neuropathol       Date:  1998-11       Impact factor: 17.088

9.  Oligodendroglioma. Histologic evaluation and prognosis.

Authors:  S J Mørk; T B Halvorsen; K F Lindegaard; G E Eide
Journal:  J Neuropathol Exp Neurol       Date:  1986-01       Impact factor: 3.685

10.  Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

Authors:  A S Chan; S Y Leung; M P Wong; S T Yuen; N Cheung; Y W Fan; L P Chung
Journal:  Am J Surg Pathol       Date:  1998-07       Impact factor: 6.394

View more
  2 in total

1.  Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis.

Authors:  Weon-Kyoo You; William B Stallcup
Journal:  Cancers (Basel)       Date:  2017-07-28       Impact factor: 6.639

2.  Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma.

Authors:  Jing Xie; Xue Kong; Wei Wang; Yuan Li; Mengyu Lin; Heng Li; Jingjing Chen; Wenchao Zhou; Jie He; Haibo Wu
Journal:  Pathol Oncol Res       Date:  2021-08-18       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.